Page 1 | Search Results | The Journal of Immunology | American Association of Immunologists

1-6 of 6

Sort by

Sort Order Select

Journal Articles

The Importance of Myeloid-Derived Suppressor Cells in the Regulation of Autoimmune Effector Cells by a Chronic Contact Eczema

Rachid Marhaba, Mario Vitacolonna, Dagmar Hildebrand, Michal Baniyash, Pia Freyschmidt-Paul, Margot Zöller

J Immunol (2007) 179 (8): 5071–5081.

https://doi.org/10.4049/jimmunol.179.8.5071

Published: 15 October 2007

View article titled, The Importance of Myeloid-Derived Suppressor Cells in the Regulation of Autoimmune Effector Cells by a Chronic Contact Eczema

Add to Citation Manager

Journal Articles

Characterization of Tumor Reactivity of Human Vγ9Vδ2 γδ T Cells In Vitro and in SCID Mice In Vivo

Dieter Kabelitz, Daniela Wesch, Elke Pitters, Margot Zöller

J Immunol (2004) 173 (11): 6767–6776.

https://doi.org/10.4049/jimmunol.173.11.6767

Published: 01 December 2004

View article titled, Characterization of Tumor Reactivity of Human Vγ9Vδ2 γδ T Cells In Vitro and in SCID Mice In Vivo

Add to Citation Manager

Journal Articles

Tumor Vaccination after Allogeneic Bone Marrow Cell Reconstitution of the Nonmyeloablatively Conditioned Tumor-Bearing Murine Host

Margot Zöller

J Immunol (2003) 171 (12): 6941–6953.

https://doi.org/10.4049/jimmunol.171.12.6941

Published: 15 December 2003

View article titled, Tumor Vaccination after Allogeneic Bone Marrow Cell Reconstitution of the Nonmyeloablatively Conditioned Tumor-Bearing Murine Host

Add to Citation Manager

Journal Articles

Prophylactic Tumor Vaccination: Comparison of Effector Mechanisms Initiated by Protein Versus DNA Vaccination

Margot Zöller, Oliver Christ

J Immunol (2001) 166 (5): 3440–3450.

https://doi.org/10.4049/jimmunol.166.5.3440

Published: 01 March 2001

View article titled, Prophylactic Tumor Vaccination: Comparison of Effector Mechanisms Initiated by Protein Versus DNA Vaccination

Add to Citation Manager

Journal Articles

In Vitro and In Vivo Induction of a Th Cell Response Toward Peptides of the Melanoma-Associated Glycoprotein 100 Protein Selected by the TEPITOPE Program

Björn Cochlovius, Marike Stassar, Oliver Christ, Laura Raddrizzani, Jürgen Hammer, Ioannis Mytilineos, Margot Zöller

J Immunol (2000) 165 (8): 4731–4741.

https://doi.org/10.4049/jimmunol.165.8.4731

Published: 15 October 2000

View article titled, In Vitro and In Vivo Induction of a Th Cell Response Toward Peptides of the Melanoma-Associated Glycoprotein 100 Protein Selected by the TEPITOPE Program

Add to Citation Manager

Journal Articles

Cutting Edge: Curative Treatment of an Experimentally Induced Colitis by a CD44 Variant V7-Specific Antibody

Bianca Wittig, Christoph Schwärzler, Nicole Föhr, Ursula Günthert, Margot Zöller

J Immunol (1998) 161 (3): 1069–1073.

https://doi.org/10.4049/jimmunol.161.3.1069

Published: 01 August 1998

View article titled, Cutting Edge: Curative Treatment of an Experimentally Induced Colitis by a CD44 Variant V7-Specific Antibody

Add to Citation Manager

NARROW

The Importance of Myeloid-Derived Suppressor Cells in the Regulation of Autoimmune Effector Cells by a Chronic Contact Eczema

Characterization of Tumor Reactivity of Human Vγ9Vδ2 γδ T Cells In Vitro and in SCID Mice In Vivo

Tumor Vaccination after Allogeneic Bone Marrow Cell Reconstitution of the Nonmyeloablatively Conditioned Tumor-Bearing Murine Host

Prophylactic Tumor Vaccination: Comparison of Effector Mechanisms Initiated by Protein Versus DNA Vaccination

In Vitro and In Vivo Induction of a Th Cell Response Toward Peptides of the Melanoma-Associated Glycoprotein 100 Protein Selected by the TEPITOPE Program

Cutting Edge: Curative Treatment of an Experimentally Induced Colitis by a CD44 Variant V7-Specific Antibody

Email alerts

Publications

Submit a Manuscript

General Information

Journal Services

The Importance of Myeloid-Derived Suppressor Cells in the Regulation of Autoimmune Effector Cells by a Chronic Contact Eczema

Characterization of Tumor Reactivity of Human Vγ9Vδ2 γδ T Cells In Vitro and in SCID Mice In Vivo

Tumor Vaccination after Allogeneic Bone Marrow Cell Reconstitution of the Nonmyeloablatively Conditioned Tumor-Bearing Murine Host

Prophylactic Tumor Vaccination: Comparison of Effector Mechanisms Initiated by Protein Versus DNA Vaccination

In Vitro and In Vivo Induction of a Th Cell Response Toward Peptides of the Melanoma-Associated Glycoprotein 100 Protein Selected by the TEPITOPE Program

Cutting Edge: Curative Treatment of an Experimentally Induced Colitis by a CD44 Variant V7-Specific Antibody

Email alerts

Publications

Submit a Manuscript

General Information

Journal Services

This Feature Is Available To Subscribers Only